SCHEMBL4615489

SCHEMBL4615489

O=C(O)N1CCN(c2cccc3c2COC(=O)N3Cc2ccccc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.45
DRD2 P14416 3/20 0.41
DRD4 P21917 3/20 0.41
DRD3 P35462 3/20 0.41
HTR7 P34969 2/20 0.41
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
GRM5 P41594 1/20 0.40
RBP4 P02753 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AR P10275 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616301 0.86 HTR6 (0.45) HTR6
SCHEMBL4613855 0.83 HTR6 (0.64) HTR6DRD2DRD4DRD3HTR7
Hydrochloric Acid SCHEMBL4614225 0.82 HTR6 (0.63) HTR6DRD2DRD4DRD3HTR7
SCHEMBL1136445 0.72 HTR6 (0.50) HTR6DRD2HTR7ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL4616525 0.71 HTR6 (0.49) HTR6DRD2HTR7ALDH1A1KMT2A
SCHEMBL5705254 0.71 DRD2 (0.42) DRD2DRD4DRD3ALDH1A1RBP4
SCHEMBL11087705 0.68 KDM4E (0.49) ALDH1A1GAARBP4KMT2AMAPT
SCHEMBL2857040 0.68 AKR1C3 (0.64) DRD2DRD4DRD3HTR7ALDH1A1
SCHEMBL7131427 0.68 ELANE (0.53) HTR6ALDH1A1KMT2AMAPTL3MBTL1
Hydrochloric Acid SCHEMBL4632915 0.68 HTR1A (0.46) HTR6DRD2DRD4DRD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708713-B1 1-BENZYL-5-PIPERAZIN-1-YL-3,4 DIHYDRO-1H-QUINAZOLIN-2-ONE DERIVATIVES AND THE RESPECTIVE 1H-BENZO(1,2,6)THIADIAZINE-2,2-DIOXIDE AND 1,4-DIHYDRO-BENZO(D)(1,3)OXAZIN-2-ONE DERIVATIVES AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT) FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM HOFFMANN LA ROCHE (CH) 2008-03-12 EP disclosed